FDA NDC Directory · JSON-LD · Markdown

Ranolazine

NDC 60290-055 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerUmedica Laboratories USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA214551
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsRANOLAZINE (500 mg/1)
Marketing started20260810
Package count2

External sources

Source: openFDA. Public-domain (CC0).